Skip to content
10-Q

Quarterly Report

ALSERES PHARMACEUTICALS INC /DE

0001193125-13-328326

← back to feed
Filed
Aug 9, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Jul 31, 2013 30.64M sh
Stock Repurchased Q2 2013 · Jun 30, 2013 $28.22K
Capex Q2 2013 · Jun 30, 2013 $1.65M
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$161.56M
Operating Cash Flow Q2 2013 · Jun 30, 2012 −$357.29K
Short Term Investments Q2 2013 · Jun 30, 2013 $25.88K
Short Term Investments Q2 2013 · Dec 31, 2012 $838.31K
Stockholders Equity Q2 2013 · Jun 30, 2013 −$27.27M
Stockholders Equity Q2 2013 · Dec 31, 2012 −$26.72M
Current Liabilities Q2 2013 · Jun 30, 2013 $9.83M
Current Liabilities Q2 2013 · Dec 31, 2012 $10.07M
Total Liabilities Q2 2013 · Jun 30, 2013 $27.04M
Total Liabilities Q2 2013 · Dec 31, 2012 $27.32M
Current Assets Q2 2013 · Jun 30, 2013 $85.22K
Current Assets Q2 2013 · Dec 31, 2012 $900.01K
Total Assets Q2 2013 · Jun 30, 2013 $147.89K
Total Assets Q2 2013 · Dec 31, 2012 $965.71K
Sga Expense Q2 2013 · Jun 30, 2013 $71.29M
Sga Expense Q2 2013 · Jun 30, 2012 $418.68K
Sga Expense Q2 2013 · Jun 30, 2012 $865.04K
Net Income Q2 2013 · Jun 30, 2013 −$199.51M
Net Income Q2 2013 · Jun 30, 2012 −$294.91K
Net Income Q2 2013 · Jun 30, 2012 −$614.21K
Operating Income Q2 2013 · Jun 30, 2013 −$197.12M
Operating Income Q2 2013 · Jun 30, 2012 −$189.22K
Operating Income Q2 2013 · Jun 30, 2012 −$406.28K
Revenue Q2 2013 · Jun 30, 2013 $1.47M
Revenue Q2 2013 · Jun 30, 2012 $250K
Revenue Q2 2013 · Jun 30, 2012 $500K
Cash And Equivalents Q2 2013 · Jun 30, 2012 $63.55K
Cash And Equivalents Q2 2013 · Dec 31, 2011 $135.84K